Literature DB >> 33430286

Immunological Characterization of Proteins Expressed by Genes Located in Mycobacterium tuberculosis-Specific Genomic Regions Encoding the ESAT6-like Proteins.

Abu Salim Mustafa1.   

Abstract

The 6 kDa early secreted antigen target (ESAT6) is a low molecular weight and highly immunogenic protein of Mycobacterium tuberculosis with relevance in the diagnosis of tuberculosis and subunit vaccine development. The gene encoding the ESAT6 protein is located in the M. tuberculosis-specific genomic region known as the region of difference (RD)1. There are 11 M. tuberculosis-specific RDs absent in all of the vaccine strains of BCG, and three of them (RD1, RD7, and RD9) encode immunodominant proteins. Each of these RDs has genes for a pair of ESAT6-like proteins. The immunological characterizations of all the possible proteins encoded by genes in RD1, RD7 and RD9 have shown that, besides ESAT-6 like proteins, several other proteins are major antigens useful for the development of subunit vaccines to substitute or supplement BCG. Furthermore, some of these proteins may replace the purified protein derivative of M. tuberculosis in the specific diagnosis of tuberculosis by using interferon-gamma release assays and/or tuberculin-type skin tests. At least three subunit vaccine candidates containing ESAT6-like proteins as antigen components of multimeric proteins have shown efficacy in phase 1 and phase II clinical trials in humans.

Entities:  

Keywords:  ESAT6-like proteins; M. tuberculosis; RD genomic segments; diagnosis; vaccine

Year:  2021        PMID: 33430286      PMCID: PMC7825740          DOI: 10.3390/vaccines9010027

Source DB:  PubMed          Journal:  Vaccines (Basel)        ISSN: 2076-393X


  212 in total

1.  PPE protein (Rv3873) from DNA segment RD1 of Mycobacterium tuberculosis: strong recognition of both specific T-cell epitopes and epitopes conserved within the PPE family.

Authors:  Limei Meng Okkels; Inger Brock; Frank Follmann; Else Marie Agger; Sandra M Arend; Tom H M Ottenhoff; Fredrik Oftung; Ida Rosenkrands; Peter Andersen
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

2.  Increased numbers of ESAT-6- and purified protein derivative-specific gamma interferon-producing cells in subclinical and active tuberculosis infection.

Authors:  T Ulrichs; P Anding; S Porcelli; S H Kaufmann; M E Munk
Journal:  Infect Immun       Date:  2000-10       Impact factor: 3.441

3.  Protection against Mycobacterium leprae infection by the ID83/GLA-SE and ID93/GLA-SE vaccines developed for tuberculosis.

Authors:  Malcolm S Duthie; Rhea N Coler; John D Laurance; Lucas H Sampaio; Regiane M Oliveira; Ana Lucia M Sousa; Mariane M A Stefani; Yumi Maeda; Masanori Matsuoka; Masahiko Makino; Steven G Reed
Journal:  Infect Immun       Date:  2014-07-14       Impact factor: 3.441

4.  Identification, diagnostic potential, and natural expression of immunodominant seroreactive peptides encoded by five Mycobacterium tuberculosis-specific genomic regions.

Authors:  Noora Y Al-Khodari; Rajaa Al-Attiyah; Abu S Mustafa
Journal:  Clin Vaccine Immunol       Date:  2010-12-22

5.  Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.

Authors:  Yih-Yuan Chen; Chih-Wei Lin; Wei-Feng Huang; Jia-Ru Chang; Ih-Jen Su; Chih-Hao Hsu; Han-Yin Cheng; Shu-Ching Hsu; Horng-Yunn Dou
Journal:  J Microbiol Immunol Infect       Date:  2014-12-11       Impact factor: 4.399

6.  Identification of variable regions in the genomes of tubercle bacilli using bacterial artificial chromosome arrays.

Authors:  S V Gordon; R Brosch; A Billault; T Garnier; K Eiglmeier; S T Cole
Journal:  Mol Microbiol       Date:  1999-05       Impact factor: 3.501

7.  Discordant QuantiFERON-TB Gold test results among US healthcare workers with increased risk of latent tuberculosis infection: a problem or solution?

Authors:  Nira R Pollock; Antonio Campos-Neto; Suely Kashino; Danielle Napolitano; Samuel M Behar; Daniel Shin; Alex Sloutsky; Swati Joshi; Jasmine Guillet; Michael Wong; Edward Nardell
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

8.  Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation.

Authors:  Kaeryn N Lewis; Reiling Liao; Kristi M Guinn; Mark J Hickey; Sherilyn Smith; Marcel A Behr; David R Sherman
Journal:  J Infect Dis       Date:  2002-12-02       Impact factor: 5.226

9.  A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates.

Authors:  Miguel J Rodo; Virginie Rozot; Elisa Nemes; One Dintwe; Mark Hatherill; Francesca Little; Thomas J Scriba
Journal:  PLoS Pathog       Date:  2019-03-04       Impact factor: 6.823

View more
  3 in total

1.  Host MKRN1-Mediated Mycobacterial PPE Protein Ubiquitination Suppresses Innate Immune Response.

Authors:  Yafeng Dou; Yan Xie; Lingyun Zhang; Sheng Liu; Dandan Xu; Yuying Wei; Yongshuai Li; Xiao-Lian Zhang
Journal:  Front Immunol       Date:  2022-05-04       Impact factor: 8.786

2.  Mycobacterium tuberculosis-Induced Upregulation of the COX-2/mPGES-1 Pathway in Human Macrophages Is Abrogated by Sulfasalazine.

Authors:  Wenfei Wang; Yuping Ning; Yejun Wang; Guofang Deng; Simona Pace; Stefanie A Barth; Christian Menge; Kehong Zhang; Youchao Dai; Yi Cai; Xinchun Chen; Oliver Werz
Journal:  Front Immunol       Date:  2022-05-19       Impact factor: 8.786

3.  The Effect of Delivery Systems on the Induction of T Helper 1 Cell Response to an ESAT6-Like Protein Rv3619c and Identification of Its Immunodominant Peptides.

Authors:  Hussain A Safar; Abu Salim Mustafa; Hanady A Amoudy; Ahmed El-Hashim
Journal:  Med Princ Pract       Date:  2022-05-18       Impact factor: 2.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.